RankingsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Operating margin (%)

ACADIA PHARMACEUTICALS INCACAD

Market cap
$3.9B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 202424.1-338.55%
Dec 31, 2023-10.1-76.63%
Dec 31, 2022-43.2+22.80%
Dec 31, 2021-35.2-45.73%
Dec 31, 2020-64.9-10.78%
Dec 31, 2019-72.7-34.23%
Dec 31, 2018-110.6-52.77%
Dec 31, 2017-234.1-85.13%
Dec 31, 2016-1,574.1-99.42%
Dec 31, 2015-269,855.7+247.34%
Dec 31, 2014-77,691.7+2222.82%
Dec 31, 2013-3,344.7+685.81%
Dec 31, 2012-425.6-61.50%
Dec 31, 2011-1,105.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)